VistaPharm Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 92

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

VistaPharm General Information

Description

Manufacturer and distributor of generic pharmaceuticals and over-the-counter products intended for the hospital market, retail pharmacy and specialized clinical setting. The company offers buprenorphine, naloxone, liquid and unit dosage, opioid treatment and pain medications, cost-effectively offering significant clinical benefits.

Contact Information

Website
www.vistapharm.com
Formerly Known As
VistaPharm, Inc.
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • 20 Waterview Boulevard
  • 3rd Floor
  • Parsippany, NJ 07054
  • United States
+1 (877)
Primary Industry
Pharmaceuticals
Parent Company
PAI Pharma
Vertical(s)
Manufacturing
Corporate Office
  • 20 Waterview Boulevard
  • 3rd Floor
  • Parsippany, NJ 07054
  • United States
+1 (877)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VistaPharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore VistaPharm‘s full profile, request access.

Request a free trial

VistaPharm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer and distributor of generic pharmaceuticals and over-the-counter products intended for the hospital market,
Pharmaceuticals
Parsippany, NJ
92 As of 2024

Baar, Switzerland
 

Nijmegen, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VistaPharm Competitors (22)

One of VistaPharm’s 22 competitors is Stallergenes Greer, a Private Equity-Backed company based in Baar, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Stallergenes Greer Private Equity-Backed Baar, Switzerland
Synthon International Holding Private Equity-Backed Nijmegen, Netherlands
LEO Pharma Private Equity-Backed Ballerup, Denmark
Avenir Wellness Solutions Formerly VC-backed Oxnard, CA
Arcutis Biotherapeutics Formerly VC-backed Westlake Village, CA
You’re viewing 5 of 22 competitors. Get the full list »

VistaPharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VistaPharm Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore VistaPharm‘s full profile, request access.

Request a free trial

VistaPharm FAQs

  • When was VistaPharm founded?

    VistaPharm was founded in 1998.

  • Where is VistaPharm headquartered?

    VistaPharm is headquartered in Parsippany, NJ.

  • What is the size of VistaPharm?

    VistaPharm has 92 total employees.

  • What industry is VistaPharm in?

    VistaPharm’s primary industry is Pharmaceuticals.

  • Is VistaPharm a private or public company?

    VistaPharm is a Private company.

  • What is VistaPharm’s current revenue?

    The current revenue for VistaPharm is .

  • Who are VistaPharm’s investors?

    Vertice Pharma has invested in VistaPharm.

  • Who are VistaPharm’s competitors?

    Stallergenes Greer, Synthon International Holding, LEO Pharma, Avenir Wellness Solutions, and Arcutis Biotherapeutics are some of the 22 competitors of VistaPharm.

  • When was VistaPharm acquired?

    VistaPharm was acquired on 11-Oct-2022.

  • Who acquired VistaPharm?

    VistaPharm was acquired by PAI Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process